AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2020
Feb 10, 2020
34301_dirs_2020-02-10_14f773fc-d2a3-4475-8c83-bc23c3f27a76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2020-02-05
Reporting Person: Sims Andrew John Hugh MacIntyre (Chief Financial Officer)
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 13